Is There a Role for Growth and Differentiation Factor-15 in B-Cell Lymphoproliferative Neoplasms?-Reference-Cited by-同舟云学术

Is There a Role for Growth and Differentiation Factor-15 in B-Cell Lymphoproliferative Neoplasms?

Published:2023-09-17 Issue: Volume: Page:
ISSN:0971-4502
Container-title:Indian Journal of Hematology and Blood Transfusion
language:en
Short-container-title:Indian J Hematol Blood Transfus

Author:

Agić Danijela^ORCID,Čabarkapa Velibor,Milošević Ivana,Perčić Ivanka,Farra Amir El,Nikolić Stanislava,Sekulić Borivoj,Vlaisavljević Nada,Savić Aleksandar,Urošević Ivana,Popović Stevan L.

Publisher

Springer Science and Business Media LLC

Subject

Hematology

Link

https://link.springer.com/content/pdf/10.1007/s12288-023-01695-6.pdf

Reference23 articles.

1. Bootcov MR, Bauskin AR, Valenzuela SM, Moore AG, Bansal M, He XY et al (1997) MIC-1, a novel macrophage inhibitory cytokine, is a divergent member of the TGF-beta superfamily. Proc Natl Acad Sci USA 94(21):11514–11519. https://doi.org/10.1073/pnas.94.21.11514

2. Emmerson PJ, Wang F, Du Y, Liu Q, Pickard RT, Gonciarz MD et al (2017) The metabolic effects of GDF15 are mediated by the orphan receptor GFRAL. Nat Med 23(10):1215–1219. https://doi.org/10.1038/nm.4393

3. Breit SN, Tsai VW, Brown DA (2017) Targeting obesity and cachexia: identification of the GFRAL receptor-MIC-1/GDF15 pathway. Trends Mol Med 23(12):1065–1067. https://doi.org/10.1016/j.molmed.2017.10.005

4. Wischhusen J, Melero I, Fridman WH (2020) Growth/differentiation factor-15 (GDF-15): from biomarker to novel targetable immune checkpoint. Front Immunol 11:951. https://doi.org/10.3389/fimmu.2020.00951

5. Tsai V, Husaini Y, Sainsbury A, Brown DA, Breit SN (2018) The MIC-1/GDF15-GFRAL pathway in energy homeostasis: implications for obesity, cachexia, and other associated diseases. Cell Metab 28(3):353–368. https://doi.org/10.1016/j.cmet.2018.07.018